Authors


Parres Wright, OD, FAAO

Latest:

Managing low vision in an aging population

As Baby Boomers enter the at-risk age group for vision loss, optometrists must be ready to act.


Andrew G. Lee, MD

Latest:

SECO 2023: Neuro nuggets with Dr Lee

Andy Lee, MD, gives highlights from his SECO special session, "Neuro nuggets."


Laurie Saloman

Latest:

In-office procedures are new option for managing cataracts, glaucoma, and lesions

As technology improves, less-invasive treatments save patients time and money.


Nidhi Rana, OD

Latest:

Identifying and treating for the appropriate red eye in pediatrics and beyond

Nidhi Rana, OD, discusses key highlights from her AAOpt 2022 presentation on pediatric red eye.


Carly Lam, PhD, MSc

Latest:

What will myopia control look like in 2034?

New long-term findings illuminate the future of DIMS spectacle lenses.


Harriette Canellos, OD, FAAO, Dipl ABO

Latest:

Meibomian gland dysfunction: At-home treatment devices

Warm compresses are an invaluable step in the treatment of dry eye.


Sonia Brujic, PharmD

Latest:

Know risks and benefits of ocular steroid use

Ophthalmic corticosteroids optimize outcomes in patients with ocular inflammatory conditions


Adam Alexander, OD

Latest:

AOA 2024: Early adoption and utilization of perfluorohexceloctane (Miebo) for dry eye disease

According to Adam Alexander, OD, Miebo can make headway in establishing a need for precision medication when it comes to dry eye treatment.



Brian Pall, OD, MS, FAAO

Latest:

Transcript: First drug-eluting contact lens approved in Japan

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.


Eric Botts, OD

Latest:

Where to begin with dry eye technology

Adding laboratory testing and meibography helps patients and practices


Arthur Jung, OD

Latest:

5 reasons optometrists have failed to embrace myopia management

Some optometrists are reluctant to incorporate myopia control into practice. With global cases on the rise, the time to act is now.


Barbara M. Wirostko, MD, FARVO

Latest:

Fact or fiction? A closer look at management options

At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.


Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO

Latest:

What's on the clinical wishlist for dry eye with Dr Bridgitte Shen Lee

Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders about what she would like to see develop as both a researcher and a clinician in the dry eye space.


Hanne Hansen, OD

Latest:

Angle closure presentation differs

Cases illustrate how acute and chronic angle-closure glaucoma are treated


Erin Tomiyama, OD, PhD, FAAO

Latest:

What you missed in glaucoma, dry eye, myopia, and more at CCS 2025

Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.


Joseph Sugg, OD

Latest:

A roundup of legislative news from 2025 so far

What to know about legislative moves that have been made through May this year.


Steven Leibowitz, MD

Latest:

Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.


Austin Lifferth, OD, FAAO

Latest:

All things glaucoma: A triad approach to evaluating the optic nerve, plus GlaucoMantras to carry with you

Austin Lifferth, OD, FAAO, shares highlights from his AAOpt 2022 presentations, including a triad approach to evaluating the optic nerve in glaucoma, and recentering glaucoma care with these 5 GlaucoMantras.


Heavin Maier, OD

Latest:

Contoured prism lenses enhance vision clarity and patient comfort

New technology improves precision of binocular vision disorder diagnosis and correction


Tracy Offerdahl, PHARMD, RPH, FAAO

Latest:

Biologic medications: The basics that every OD should know

This drug category is rapidly growing in the ophthalmic space, with more options in the pipeline


Sheri Rowen, MD, FACS, PCEO, FCWS

Latest:

Pearls for integrating dry eye disease management into your practice

Collaboration between ophthalmologists, optometrists can boost early detection.


Lotfi Merabet, OD, PhD, MPH

Latest:

Cerebral visual impairment

Documenting the visual effects and simplifying visual life.


Jeffrey Anshel, OD, FAAO

Latest:

Picking the right nutraceuticals for eye health supplementation

Jeffrey Anshel, OD, FAAO, outlines integrating nutritional supplements into patient eye care.



Lenna Walker OD, MS, FAAO

Latest:

Case report: OCT in the detection and diagnosis of neurofibromatosis type 1

Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.


Andrew S. Bruce, LDO, ABOM, NCLEM, FCLSA

Latest:

VEW 2024: Contact Lens Institute survey reveals factors that keep patients in contact lenses

The Contact Lens Institute unveiled a preview of their data on contact lens patient retention at Vision Expo West. The full report will be released later this year.


Chris Maraboli

Latest:

Open Your Eyes documentary released on multiple platforms

Open Your Eyes documentary now available on Apple TV+ and Google Play!


Jay M. Haynie, OD, FAAO, FORS

Latest:

Victoria Conference 2023: Staying current with the AMD landscape

Jay M. Haynie, OD, FAAO, FORS, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from his presentation on staying current with the AMD landscape.


Noor Chahal, BS

Latest:

Study finds significant variance across imaging modalities on sizes of geographic atrophy areas

A single, consistent modality leads to better geographic atrophy tracking.

© 2025 MJH Life Sciences

All rights reserved.